Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05230_nanopub.RA0O7Teuczzf0laS-vitvGJSC71LsXRiQ9UE_1Mm26U48#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05230 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05230 label "AC3056 [drugbank:DB05230]" assertion.
- drugbank:DB05230 seeAlso DB05230 assertion.
- drugbank:DB05230 description "AC3056 is a non-peptide antioxidant that acts as an inhibitor of vascular cell adhesion molecule expression originally developed by Aventis Pharmaceuticals. It as since been acquired by Amylin Pharmaceuticals and has completed phase I trials." assertion.
- drugbank:DB05230 identifier "drugbank:DB05230" assertion.
- drugbank:DB05230 title "AC3056" assertion.
- drugbank:DB05230 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05230 drugbank_vocabulary:drugbank-id "DB05230" assertion.
- drugbank:DB05230 bio2rdf_vocabulary:x-identifiers.org DB05230 assertion.
- drugbank:DB05230 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05230" assertion.
- drugbank:DB05230 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05230 bio2rdf_vocabulary:identifier "DB05230" assertion.